Tuesday, 02 January 2024 12:17 GMT

$443.6 Bn Microtome Global Market Trends, Opportunities And Strategies, 2019-2024, 2025-2029F, 2034F: Top 10 Players Hold 26.56% Share Led By Danaher, Thermo Fisher Scientific, And Sakura Finetek


(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the microtome market lie in expanding technical centers for innovation, focusing on next-gen microtomes and automation to enhance precision, and tapping into emerging markets. Growth is driven by disease diagnosis and drug discovery needs, with the accessories and fully automated segments showing promise.

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Microtome Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets's offering.

The microtome market report forecasts significant growth, evaluating the market by regions, major economies, products, technology, applications, and end-users. The global microtome market was valued at approximately $244.63 million in 2024, with a compound annual growth rate (CAGR) of 4.24% since 2019. This is anticipated to grow to $335.05 million by 2029, at a CAGR of 6.49%, and reach $443.58 million by 2034 with a rate of 5.77%.

Key growth drivers include the rising focus on personalized medicine, increasing clinical trials, and advancements in 3D tissue and organoid research. Challenges faced during the historical period include the high costs of advanced equipment and a scarcity of skilled technicians. Future growth will be fueled by increased applications in drug discovery, toxicology studies, expanding research facilities, and advancements in regenerative medicine and stem cell research. However, hurdles such as mechanical complexity, calibration demands, and geopolitical trade issues might impact the market.

In 2024, North America dominated the microtome market with a 35.61% share or $87.1 million, followed by Asia-Pacific, Western Europe, and other regions. The fastest-growing regions are expected to be Asia-Pacific and Western Europe, with CAGRs of 7.12% and 7.03%, respectively. The Middle East and North America are projected to have CAGRs of 6.42% and 6.24% respectively.

The market remains fairly concentrated, with the top 10 competitors holding 26.56% of the market in 2024. Leading players include Danaher Corporation (4.49%), Thermo Fisher Scientific Inc. (3.31%), and Sakura Finetek Inc. (3.07%). Other significant players are Cardinal Health Inc., BIOBASE Group, and AGD Biomedicals Pty Ltd.

The microtome market is segmented by product into instruments and accessories. Instruments comprise the largest segment, representing 67.50% or $165.13 million in 2024. However, the accessories segment is expected to grow fastest, with a forecasted CAGR of 10.40% for 2024-2029.

By technology, the market is segmented into fully automated, semi-automated, and manual microtomes. Fully automated microtomes led the market in 2024, accounting for 54.36% or $132.98 million. This segment is projected to maintain the fastest growth with a CAGR of 7.09% from 2024-2029.

Applications of microtomes are divided into disease diagnosis and medical research, with disease diagnosis leading at 65.19% or $159.47 million in 2024. It will continue to be the fastest-growing application, projected at a CAGR of 7.57% for 2024-2029.

The market's end-user segments include hospitals, clinical and diagnostic laboratories, academic research centers, and others. Hospitals held the largest share at 36.55% or $89.42 million in 2024. The clinical and diagnostic laboratories segment is expected to grow at a CAGR of 7.90% during 2024-2029.

The report highlights opportunities for growth, especially in the instruments segment, expected to gain $39.54 million. The fully automated technology segment will see a $54.3 million increase, while the disease diagnosis application is set to rise by $70.16 million. Among end-users, the hospitals segment will gain $31.07 million by 2029, with the USA predicting a $27.47 million increase.

Strategic recommendations include emphasizing technical center expansions for innovation, focusing on the development of next-generation microtomes, and improving automation technologies for precision. Companies are advised to target growth in the accessories segment, emerging markets, and developed markets, alongside focusing on competitive pricing and B2B promotions.

Key Attributes:

Report Attribute Details
No. of Pages 325
Forecast Period 2024 - 2034
Estimated Market Value (USD) in 2024 $244.6 Million
Forecasted Market Value (USD) by 2034 $443.6 Million
Compound Annual Growth Rate 6.1%
Regions Covered Global


Report Chapters Include:

  • Introduction and Market Characteristics - Outlines market segmentations by product, technology, application, and end-user.
  • Key Trends - Discusses major global trends and anticipated future market developments.
  • Growth Analysis - Provides strategic analysis using PESTEL framework and captures historic and forecast market values alongside growth drivers and challenges.
  • Global Market Growth - Examines market values and growth rates for both historic and future periods.
  • Regional Analysis - Offers country-specific data with comparative growth insights.
  • Market Segmentation - Detailed analysis by product type, technology, application, and end-user.
  • Competitive Landscape - Profiles leading players and documents market share dynamics.
  • Market Opportunities and Strategies - Identifies potential opportunities and strategic directions for market participants.
  • Key Market Players: Notable companies include Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Cardinal Health, and BIOBASE Group.

Companies Featured

  • Danaher Corporation (Leica Biosystems)
  • Thermo Fisher Scientific Inc. (Fisher Scientific)
  • Sakura Finetek Inc.
  • Cardinal Health Inc.
  • BIOBASE Group
  • AGD Biomedicals pty Ltd.
  • RWD Life Science Co. Ltd.
  • Campden Instruments
  • RMC Boeckeler Instruments Inc.
  • SLEE Medical GmbH
  • Milestone Medical
  • Jinhua YIDI Medical Appliance Co., Ltd
  • Medimeas Instruments
  • Histo-Line Laboratories
  • Shenzhen Dakewei Biotechnology Co., Ltd.
  • Radical Scientific Equipments Pvt. Ltd
  • MGI Tech Co., Ltd.
  • ZEISS India
  • Jinhua Hisure Scientific Co., Ltd
  • Nippon Medical & Chemical Instruments Co., Ltd.
  • FEATHER Safety Razor Co., Ltd
  • GD (GangDong) Group Co., Ltd
  • Carl Zeiss AG
  • Diapath S.p.A.
  • microTec Laborgerate GmbH
  • MEDITE Medical GmbH
  • CellPath Ltd
  • Pathotec AG
  • Myr, S.L.
  • Microm Limited
  • Lutz Blades GmbH & Co. KG
  • Clarapath Inc
  • Microtome Precision Inc
  • Lupetec Pathology Equipments
  • Gulf Support Centre
  • Laboid International
  • ISAM Kenya

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Microtome Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN08012026004107003653ID1110572460



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search